A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021
The survey results indicated that in 2021, compared with 2020, more experts opted to administer IO + TKI for the treatment of liver cancer, and more experts and patients were willing to participate in clinical research.
Authors
- Aiping Zhou
- Jianqiang Cai (ORCID: https://orcid.org/0000-0002-3426-4579)
- Hui‐Chuan Sun (ORCID: https://orcid.org/0000-0003-3761-7058)
- Ruibao Liu (ORCID: https://orcid.org/0000-0002-8740-2306)
- Lianxin Liu (ORCID: https://orcid.org/0000-0002-3535-6467)
- Jie Shen (ORCID: https://orcid.org/0000-0003-3157-4640)
- Q.S. Li (ORCID: https://orcid.org/0000-0002-4822-2863)
- Chaoliu Dai (ORCID: https://orcid.org/0000-0002-5122-2792)
- Hong Zhao (ORCID: https://orcid.org/0000-0002-6063-2099)
- Zuoxing Niu (ORCID: https://orcid.org/0000-0001-6709-7298)
- Zhengqiang Yang (ORCID: https://orcid.org/0000-0001-9103-3534)
- Ming Zhao (ORCID: https://orcid.org/0000-0002-1025-8895)
- Chunyi Hao (ORCID: https://orcid.org/0000-0002-1233-1689)
- Yilei Mao (ORCID: https://orcid.org/0000-0003-0449-4223)
- Hongmei Zhang (ORCID: https://orcid.org/0000-0002-1284-5786)
- Yongjun Chen (ORCID: https://orcid.org/0000-0002-6486-2000)
- Jian Zhen Yu (ORCID: https://orcid.org/0000-0002-6165-6500)
- Tao Li (ORCID: https://orcid.org/0000-0001-7586-9841)
- Zhiyong Huang (ORCID: https://orcid.org/0000-0002-2239-0674)
- Xiaodong Wang (ORCID: https://orcid.org/0000-0003-4727-9742)
- Yue Han (ORCID: https://orcid.org/0000-0002-7395-7095)
- Jingdong Zhang (ORCID: https://orcid.org/0000-0002-0711-2764)
- Yajin Chen (ORCID: https://orcid.org/0000-0002-7612-9033)
- Hongguang Wang (ORCID: https://orcid.org/0000-0002-7620-614X)
- Tianfu Wen (ORCID: https://orcid.org/0000-0003-1979-9775)
- Xiangchen Li (ORCID: https://orcid.org/0000-0001-9312-3306)
- Weiping Zhou (ORCID: https://orcid.org/0000-0003-4013-3863)
- Jun Zhou (ORCID: https://orcid.org/0000-0003-0642-8676)
- Feng Shen (ORCID: https://orcid.org/0000-0003-1767-5437)
- Xiaoming Chen (ORCID: https://orcid.org/0000-0003-2770-8028)
- Li Gong (ORCID: https://orcid.org/0009-0008-1774-4619)
- Wei Zhang (ORCID: https://orcid.org/0000-0003-4950-3242)
- Zhen-Gang Yuan
- Minshan Chen (ORCID: https://orcid.org/0000-0002-6116-5015)
- Feng Wen (ORCID: https://orcid.org/0009-0009-6203-0559)
- Lei Zhao (ORCID: https://orcid.org/0000-0002-9919-5981)
- Ningling Ge
- Xinyu Bi
- Jian Zhai
Institutions
- University of Science and Technology of China (CN)
- Harbin Medical University (CN)
- Sun Yat-sen University (CN)
- Second Military Medical University (CN)
- Shanghai Jiao Tong University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Sichuan University (CN)
- Fudan University (CN)
- Peking Union Medical College Hospital (CN)
- Ruijin Hospital (CN)
- West China Hospital of Sichuan University (CN)
- Peking University Cancer Hospital (CN)
- Sun Yat-sen Memorial Hospital (CN)
- Shandong Tumor Hospital (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Second Hospital of Shandong University (CN)
- Nanjing Drum Tower Hospital (CN)
- Zhongshan Hospital (CN)
- Eastern Hepatobiliary Surgery Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Jiangsu Province Hospital (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Guangdong Provincial People's Hospital (CN)
- Xijing Hospital (CN)
- Tongji Hospital (CN)
- Liaoning Cancer Hospital & Institute (CN)
- Shandong First Medical University (CN)
- First Affiliated Hospital Zhejiang University (CN)
- State Key Laboratory of Oncology in South China
- Huazhong University of Science and Technology (CN)
- Nanjing Medical University (CN)
- China Medical University (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Cancer Innovation
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1002/cai2.70006
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00